Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?

被引:1
|
作者
Huang, Jiao-Bao [1 ,2 ,3 ]
Lu, Jun [1 ,2 ,3 ]
Wu, Dong [1 ,2 ,3 ]
Xu, Bin-bin [1 ,2 ,3 ]
Xue, Zhen [1 ,2 ,3 ]
Lin, Guo-Sheng [1 ,2 ,3 ]
Zheng, Hua-Long [1 ,2 ,3 ]
Shen, Li-Li [1 ,2 ,3 ]
Lin, Jia [1 ,2 ,3 ]
Xie, Jian-Wei [1 ,2 ,3 ]
Wang, Jia-Bin [1 ,2 ,3 ]
Lin, Jian-Xian [1 ,2 ,3 ]
Chen, Qi-Yue [1 ,2 ,3 ]
Cao, Long-Long [1 ,2 ,3 ]
Zheng, Chao-Hui [1 ,2 ,3 ]
Huang, Chang-Ming [1 ,2 ,3 ]
Li, Ping [1 ,2 ,3 ]
机构
[1] Fujian Med Univ, Dept Gastr Surg, Union Hosp, Fuzhou, Peoples R China
[2] Fujian Med Univ, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Peoples R China
[3] Fujian Med Univ, Fujian Key Lab Tumor Microbiol, Fuzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
gastric cancer; pathological staging version; adjuvant chemotherapy; surgery; perineural invasion positive; PERINEURAL INVASION; NEURAL INVASION; PHASE-III; OXALIPLATIN; TRIAL; S-1;
D O I
10.3389/fonc.2021.712432
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The efficacy and benefits of adjuvant chemotherapy (AC) for patients with gastric cancer pT3N0M0 remain controversial. Methods We prospectively collected and retrospectively analyzed 235 patients with pT3N0M0 gastric cancer who underwent radical resection between February 2010 and January 2016. Patients were divided into two groups: the surgery-alone (SA) group (n = 82) and the AC group (n = 153). We analyzed the effects of AC on the overall survival (OS) and recurrence-free survival (RFS), and the relationship between the number of chemotherapy cycles (CC) and recurrence rate (RR). Results The 5-year OS and RFS of the participants were 80.9% and 87.7%, respectively, and those in the AC group were significantly higher than those in the SA group (86.9% vs. 69.5%, p = 0.003). The RFS of the AC and SA groups were 88.9% and 85.4%, respectively; the difference was not statistically significant (p = 0.35). The independent risk factors affecting the OS were perineural invasion-positive (PNI+) (HR = 2.64, 95%CI: 1.45-4.82, p = 0.003) and age >= 65 years (HR = 2.58, 95%CI: 1.39-4.8, p = 0.003). The independent risk factor affecting the RFS was also PNI+ (HR3.11; 95%CI: 1.48-6.54, p = 0.003). Stratified analysis revealed that postoperative AC can significantly improve the OS of PNI+ patients (AC group versus SA group: 84.1% vs. 45.5%, p = 0.001) and RFS (86.4% vs. 63.6%, p = 0.017). However, perineural invasion negative (PNI-) patients did not show the same results (p = 0.13 and p = 0.48, respectively). According to the number of CC, divided into CC < 3 groups and CC >= 3 groups, the cumulative RR in the CC >= 3 group of patients with PNI+ was significantly lower than that of the CC < 3 group (7.4% vs. 28.2%, p = 0.037). Conclusion For pT3N0M0 gastric cancer patients with PNI+, at least three cycles of postoperative AC can significantly reduce the overall RR. This finding should be verified by using large external sample data.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer
    Kang, Minseo
    Youn, Ho Geun
    An, Ji Yeong
    Choi, Min-Gew
    Lee, Jun Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Kim, Sung
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1437 - 1444
  • [2] Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer
    Minseo Kang
    Ho Geun Youn
    Ji Yeong An
    Min-Gew Choi
    Jun Ho Lee
    Tae Sung Sohn
    Jae Moon Bae
    Sung Kim
    [J]. Annals of Surgical Oncology, 2021, 28 : 1437 - 1444
  • [3] pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Michel Bolla
    Laurence Collette
    [J]. Nature Reviews Urology, 2009, 6 : 410 - 412
  • [4] The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma
    Huang, Yun-Ching
    Chen, Miao-Fen
    Shi, Chung-Sheng
    Shindel, Alan W.
    Huang, Cih-En
    Pang, See-Tong
    Chuang, Cheng-Keng
    Chen, Chih-Shou
    Chang, Ying-Hsu
    Lin, Wei-Yu
    Ho, Dong-Ru
    Chin, Chih-Chien
    Kuo, Yi-Hung
    Wu, Ching-Fang
    [J]. JOURNAL OF UROLOGY, 2015, 194 (02): : 323 - 329
  • [5] PROSTATE CANCER pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Bolla, Michel
    Collette, Laurence
    [J]. NATURE REVIEWS UROLOGY, 2009, 6 (08) : 410 - 412
  • [6] Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery
    Pei, Su
    Huang, Jiang-Qiong
    Liang, Huan-Wei
    Liu, Yang
    Chen, Long
    Yu, Bin-Bin
    Huang, Wei
    Pan, Xin-Bin
    [J]. DISEASES OF THE ESOPHAGUS, 2024, 37 (08)
  • [7] Intraoperative Radiotherapy in the Combination of Adjuvant Chemotherapy for the Treatment of pT3N0M0 Rectal Cancer After Radical Surgery
    Zhang, Qing
    Tey, Jeremy
    Yang, Zhe
    Li, Ping
    Peng, Lihua
    Jiang, Ruiyao
    Xiong, Fei
    Fu, Shen
    Lu, Jiade J.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 8 - 12
  • [8] The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma EDITORIAL COMMENT
    Sagalowsky, Arthur I.
    [J]. JOURNAL OF UROLOGY, 2015, 194 (02): : 329 - 329
  • [9] Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract
    Lee, Sang Eun
    Byun, Seok-Soo
    Park, Yong Hyun
    Chang, In Ho
    Kim, Yong June
    Hong, Sung Kyu
    [J]. UROLOGIA INTERNATIONALIS, 2006, 77 (01) : 22 - 26
  • [10] Outcomes in Patients with pT3N0M0 Breast Cancer with and without Postmastectomy Radiotherapy
    Li, Chunyan
    Wang, Jiangfeng
    Mo, Miao
    Yuan, Jing
    Luo, Jurui
    Jin, Kairui
    Wang, Xuanyi
    Yang, Yilan
    Ma, Jinli
    Mei, Xin
    Yang, Zhaozhi
    Yu, Xiaoli
    Guo, Xiaomao
    Chen, Xingxing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3889 - 3899